Pharmacotherapy of parkinson`s Disease
(Sprache: Englisch)
Intrinsically, the substantia nigra pars compacta (SNc) is a region characterized by high levels of oxidative stress because free radicals are generated from dopamine degradation (mediated by MAO; Figure 1). Several antioxidative molecules (e.g.,...
Leider schon ausverkauft
versandkostenfrei
Buch
39.90 €
Produktdetails
Produktinformationen zu „Pharmacotherapy of parkinson`s Disease “
Klappentext zu „Pharmacotherapy of parkinson`s Disease “
Intrinsically, the substantia nigra pars compacta (SNc) is a region characterized by high levels of oxidative stress because free radicals are generated from dopamine degradation (mediated by MAO; Figure 1). Several antioxidative molecules (e.g., glutathione) are present in the SNc to limit damage produced by free-radical reactions, but in PD, such protection might be overwhelmed or impaired. Thus, cellular damage from oxidant stress has long been discussed as an etiopathology component of PD. The SNc is also rich in iron and copper, essential cofactors in the biosynthesis and metabolism of dopamine. The oxidation-reduction cycle of iron can also generate free radicals and toxic metabolites (Fig. 1). In addition, apoptosis (programmed cell death), excitotoxicity, inflammation, mitochondrial dysfunction, nitric oxide toxicity, proteasomal dysfunction, and autophagic cellular mechanisms are also implicated etiopathology mechanisms in PD.
Autoren-Porträt von Yazachew Engida
Engida, YazachewI am an instructor at Bahir Dar University. I engaged in teaching, research, and publication. Currently, I am working on articles both individually and with teams.
Bibliographische Angaben
- Autor: Yazachew Engida
- 68 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 6202787600
- ISBN-13: 9786202787604
Sprache:
Englisch
Kommentar zu "Pharmacotherapy of parkinson`s Disease"
0 Gebrauchte Artikel zu „Pharmacotherapy of parkinson`s Disease“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Pharmacotherapy of parkinson`s Disease".
Kommentar verfassen